BRM4 Shown to Triple Natural Killer (NK) Cell Activity

November 17, 2008

Daiwa Health Development has introduced double strength BRM4 ®, a 500mg, 60 count version of its patented immune enhancing complex to the health professional marketplace. BRM4 ®, with its active ingredient Rice Bran Arabinoxylan Compound (RBAC).

BRM4 ® in a 250mg dosage, 60 count bottle, has been available through physicians for over 10 years. In pre-clinical studies, the power of BRM4 ® multiplies T cell levels up to 200%. The enhanced activity of helper T cells promotes the proliferation of cytotoxic T and B cells for essential immune support. Helper T cells also signal plasma B cells when they encounter their cognate antigen to secure a health production of antibodies. Furthermore, BRM4 ® supports the body’s natural production of cytokines to control inflammatory response.(Los Angeles, CA) November 17, 2008 – Daiwa Health Development has introduced double strength BRM4 ®, a 500mg, 60 count version of its patented immune enhancing complex to the health professional marketplace. BRM4 ®, with its active ingredient Rice Bran Arabinoxylan Compound (RBAC), has been clinically shown to triple Natural Killer (NK) cell activity, increase T and B lymphocytes and demonstrate vital antioxidant and anti-inflammatory action.                                                                                     

RBAC, a polysaccharide dietary fiber derived from rice bran, is modified by a Shiitake mushroom enzyme using a patented biotechnology process. As an immune modulator, BRM4 ® retains its effectiveness over time. Clinical trials have shown BRM4 ® is safe with no side effects. In over 12 years of worldwide use, there have been no reported cases of drug interactions. BRM4 ® is recognized as the gold standard immune product worldwide for people with seriously compromised immune systems.

Double Strength BRM4 ® is now available to health professionals in the U.S. For more product and ordering information call 877-4DHDMED (877-434-3633) or email info@dhdmed.com

Los Angeles-based Daiwa Health Development, Inc. is a subsidiary of Daiwa Pharmaceutical Co. Ltd. based in Tokyo, Japan. Daiwa has become a leading research and manufacturing company, striving to create new value in the field of bioscience. Daiwa focuses on the manufacturing and distribution of nutraceuticals, functional foods and cosmetics.
 




Leave a comment

Comments will be approved before showing up.


Also in News

Flu Prevention in the Time of Covid
Flu Prevention in the Time of Covid

November 20, 2020

It’s flu season again and this year, it is likely that flu viruses will be spreading together with Covid. Taking extra precautions to prevent flu is very important not just for our own well-being but also for our healthcare system that is already overburdened because of Covid.

Continue Reading

Promising Benefits of RBAC on Canines
Promising Benefits of RBAC on Canines

November 12, 2020

The immune system of humans and canines are closely related. Canines have been studied as better models of immune therapy for humans compared to the use of mice. Studies have revealed that there are phenotypic and functional similarities between NK cells of humans and canines. 

Continue Reading

Plasmanex1 - A Functional Food for Metabolic Disorders
Plasmanex1 - A Functional Food for Metabolic Disorders

October 19, 2020

The results from Dr. Pescatore’s study showed that Plasmanex1 has the likelihood to improve lipid metabolism as seen in the maintenance of healthy total cholesterol, LDL cholesterol and triglyceride levels. Glycated hemoglobin or HbA1c is a marker of one’s blood glucose level within the last three months. It is a good indicator of the risk for diabetes and its complications. 

Continue Reading

*** WHAT'S NEW ***

Subscribe and SAVE 5% off on all products! 

Please be advised that due to high demand and unusual volume of BRM4 orders, we are limiting 5 bottles per customer. Should you need more, please contact our office.

Sign Up now for Promotions and Updates >>>